Engineered biosynthesis of β‐alkyl tryptophan analogs
Abstract
Noncanonical amino acids (ncAAs) with dual stereocenters at the α and β positions are valuable precursors to natural products and therapeutics. Despite the potential applications of such bioactive β‐branched ncAAs, their availability is limited due to the inefficiency of the multistep methods used to prepare them. Herein we report a stereoselective biocatalytic synthesis of β‐branched tryptophan analogues using an engineered variant of Pyrococcus furiosus tryptophan synthase (PfTrpB), PfTrpB^(7E6). PfTrpB^(7E6) is the first biocatalyst to synthesize bulky β‐branched tryptophan analogues in a single step, with demonstrated access to 27 ncAAs. The molecular basis for the efficient catalysis and broad substrate tolerance of PfTrpB^(7E6) was explored through X‐ray crystallography and UV/Vis spectroscopy, which revealed that a combination of active‐site and remote mutations increase the abundance and persistence of a key reactive intermediate. PfTrpB^(7E6) provides an operationally simple and environmentally benign platform for the preparation of β‐branched tryptophan building blocks.
Additional Information
© 2018 Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim. Manuscript received: July 15, 2018; Accepted manuscript online: September 14, 2018; Version of record online: October 12, 2018. We thank Dr. David Romney, Patrick Almhjell, Dr. Christopher Prier, Nathaniel Goldberg, and Ella Watkins for helpful discussions and comments on the manuscript. We thank Dr. Jens Kaiser of the Caltech Molecular Observatory, Dr. Scott Virgil and the Center for Catalysis and Chemical Synthesis, and Dr. Mona Shahgholi and Naseem Torian from the Caltech Mass Spectrometry Laboratory. This research was funded by the Rothenberg Innovation Initiative. C.E.B. was supported by a postdoctoral fellowship from the Resnick Sustainability Institute. R.A.S. was supported by funding from the University of Groningen. Conflict of interest: The enzyme variants and tryptophan analogues in this manuscript are the subject of a patent application submitted by the authors and Caltech.Attached Files
Accepted Version - anie.201807998.pdf
Submitted - Boville_2018_ChemRxiv.pdf
Supplemental Material - Supplemental_Information_ChemRxiv.pdf
Supplemental Material - anie201807998-s1-c_supporting_information.pdf
Files
Additional details
- Eprint ID
- 88128
- Resolver ID
- CaltechAUTHORS:20180723-111237018
- Rothenberg Innovation Initiative (RI2)
- Resnick Sustainability Institute
- University of Groningen
- Created
-
2018-07-23Created from EPrint's datestamp field
- Updated
-
2023-06-01Created from EPrint's last_modified field
- Caltech groups
- Resnick Sustainability Institute